Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    RETINOSCHISIS 1, X-LINKED, JUVENILE
Show Display Options
Rank Status Study
1 Recruiting Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis
Condition: Gene Transfer
Intervention: Biological: RS1 AAV Vector
2 Enrolling by invitation People s Expectations When Enrolling in a Phase I/II RS1 Ocular Gene Transfer Clinical Trial
Conditions: Retinoschisis;   X-Linked
3 Completed Evaluate the Efficacy and Safety of N02RS1 in Patient With Acute Bronchitis
Condition: Acute Bronchitis
Interventions: Drug: N02RS1 1200mg;   Drug: Placebo
4 Completed Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis
Condition: Acute Exacerbation of Chronic Bronchitis
Intervention: Drug: Combination of Broussonetia spp and Lonicera spp
5 Recruiting Safety and Efficacy of rAAV-hRS1 in Patients With X-linked Retinoschisis (XLRS)
Condition: X-linked Retinoschisis
Intervention: Biological: rAAV2tYF-CB-hRS1
6 Active, not recruiting Clinical Evaluation of Patients With X-linked Retinoschisis
Conditions: X-linked Retinoschisis;   XLRS
Intervention: Drug: Dorzolamide 2% TID or brinzolamide 1% TID

Indicates status has not been verified in more than two years